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Aptamers are structured macromolecules in vitro
evolved to bind molecular targets, whereas in nature
they form the ligand-binding domains of ribos-
witches. Adenosine aptamers of a single structural
family were isolated several times from random
pools, but they have not been identified in genomic
sequences. We used two unbiased methods, struc-
ture-based bioinformatics and human genome-
based in vitro selection, to identify aptamers that
form the same adenosine-binding structure in a
bacterium, and several vertebrates, including hu-
mans. Two of the human aptamers map to introns
of RAB3C and FGD3 genes. The RAB3C aptamer
binds ATP with dissociation constants about 10
times lower than physiological ATP concentration,
while the minimal FGD3 aptamer binds ATP only
cotranscriptionally.
INTRODUCTION
Functional nucleic acids fold into specific structures that
form the physicochemical foundations for their activity, which
includes catalysis and ligand binding. Among the best character-
ized functional RNAs are aptamers, oligoribonucleotides in vitro
selected to bind target molecules with high affinity and/or spec-
ificity (Ellington and Szostak, 1990; Stoltenburg et al., 2007;
Tuerk and Gold, 1990). In general, the aptamer structures con-
sist of the ligand-binding pockets formed by folding of single-
stranded regions of specific sequence and flanking helical
regions that are typically sequence independent (Riccitelli and
Lupta´k, 2010). When the target is a small molecule (e.g., a
metabolite), the aptamer often forms a buried binding site with
extensive hydrogen bonding and van der Waals interactions
that give rise to the ligand-binding characteristics. The flanking
helical regions contribute to the strength of the interaction by
stabilizing the ligand-binding structure but can also be used as
transduction domains for signaling the presence of the ligandChemistry & Biology 19, 1247–1in the binding site by switching between two alternative pairing
interactions (Breaker, 2011).
One of the most extensively characterized aptamers is a
simple motif that binds adenosine. The aptamer was first identi-
fied in an in vitro selection for ATP-binding RNAs (Sassanfar and
Szostak, 1993), and later in several independent selection ex-
periments targeting adenosine-containing cofactors, including
nicotinamide adenine dinucleotide (Burgstaller and Famulok,
1994), S-adenosyl methionine (Burke andGold, 1997), and S-ad-
enosylhomocysteine (Gebhardt et al., 2000). The aptamer recog-
nizes adenosine and its 50 phosphorylated analogs by an 11
nucleotide (nt) loop and a bulged guanosine located on the
opposite strand. Solution structures of AMP-bound complexes
revealed that the conserved recognition loop folds into a com-
pact binding site that contacts the Watson-Crick face of the
nucleobase and the 20 position of the ribose (Dieckmann et al.,
1996, 1997; Jiang et al., 1996), explaining the binding specificity
for adenine ribonucleoside and tolerance to substitutions at
the 80 and 50 positions (Sassanfar and Szostak, 1993). The repro-
ducible isolation of this motif from random sequences suggests
that it is the simplest adenosine-binding structure, providing a
striking example of convergent molecular evolution. Despite
this structural convergence in vitro, the aptamer has not been
identified in genomic sequences; therefore, it has not been
known whether the convergence extends to biological systems
and whether biological ligand-binding RNAs, particularly ribos-
witches, utilize this motif for regulatory or other functions.
Riboswitches are functional RNAs composed of aptamer
domains and expression platforms, which bindmolecular targets
and regulate gene expression, respectively (Breaker, 2011).
Most riboswitches have been found in bacteria, with a single
example described in algae, fungi, and plants but not other
eukaryotes (Cheah et al., 2007; Croft et al., 2007; Kubodera
et al., 2003; Wachter et al., 2007). The aptamer domains of the
riboswitches constitute a diverse set of RNA structures, ranging
from three-way junctions to intricate pseudoknots (Montange
and Batey, 2008); however, these motifs are different from
in vitro-selected aptamers targeting the same ligands. This
observation suggests that in vitro-selected and biological ap-
tamer domains follow separate evolutionary pathways, perhaps
because aptamers evolved in vitro are optimized for target bind-
ing and efficiency of amplification during the selection process,254, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1247
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Figure 1. Genomic Adenosine Aptamers Uncovered Using Structure-Based Bioinformatics
(A and B) Secondary structure descriptors for the in vitro-selected adenosine aptamer, with the recognition loop (shown in bold) in (A) the 50 strand or (B) the 30
strand. Both topologies have been identified in vitro (Burgstaller and Famulok, 1994; Sassanfar and Szostak, 1993). The bulged guanosine required for ligand
binding is outlined on a strand opposite of the recognition loop.
(C) Sequences of aptamers that showed robust ATP binding in vitro. Fraction of each RNA eluted from ATP-agarose beads in the presence of 5 mM ATP-Mg and
genomic locations of the aptamers are listed on the right. Outer and inner helices of the structure are marked as H1 and H2, respectively. The B. cytotoxicus
sequence has the recognition loop in the 30 segment of the aptamer.
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Human ATP Aptamerswhereas the riboswitch motifs have evolved to couple target
binding to gene expression regulation. On the other hand, the
methods used to identify the aptamer domains in synthetic
and biological sequences are distinct, relying on in vitro selec-
tion and phylogenetic conservation of the aptamer structure,
respectively, and may thus bias the identified motifs. More-
over, in vitro-selected aptamers are typically smaller than
riboswitches, in part because the length of the starting selec-
tion pool tends to be shorter than the typical riboswitch. In
principle, however, the motifs recognizing the same ligand can
be isolated from random sequences and identified in genomic
sequences, especially if the methods used are amenable to
the discovery of simple RNA motifs that may be abundant in
both sequence sets.
To test whether in vitro-identified aptamer motifs exist in
genomic sequences, we used structure-based searches (Ricci-
telli and Lupta´k, 2010) and identified adenosine aptamers in
a bacterium and several vertebrates, including humans. Further-
more, to identify all adenosine-binding RNAs encoded in the
human genome, independent of structure, we performed an
in vitro selection for ATP-binding transcripts of a human genomic
pool (Salehi-Ashtiani et al., 2006) and discovered two more
aptamers. It is surprising that both aptamers fold into the same
structure as was identified in vitro. Two of the three human
aptamers map to introns of expressed genes and may sense
ATP concentration through a kinetic mechanism.
RESULTS
Structure-Based Search for Genomic Adenosine
Aptamers
We performed the motif searches by designing a descriptor for
the adenosine aptamer structure, based on the known sequence
variants and solution structures (Burgstaller and Famulok, 1994;
Burke and Gold, 1997; Dieckmann et al., 1996, 1997; Gebhardt
et al., 2000; Jiang et al., 1996; Sassanfar and Szostak, 1993).1248 Chemistry & Biology 19, 1247–1254, October 26, 2012 ª2012 EThe aptamers recognize any adenosine-containing molecule
with exposed ribose and adenine moieties using a conserved
11 nt loop opposite to a single guanosine and flanked by two
helical segments (Figures 1A and 1B). Because of its asymmetry,
the adenosine-binding loop can be incorporated into the flanking
sequences through either of two topologies, with the loop in
either the 50 or the 30 strand of the aptamer, requiring two sepa-
rate descriptors (Riccitelli and Lupta´k, 2010). Both topologies
have been identified among in vitro-selected sequences, with
a slight preference for the loop in the 50 strand (Burke and
Gold, 1997; Sassanfar and Szostak, 1993); thus, we designed
descriptors for both orientations. Whereas the aptamer fold
is simple, its information content (R35 bits; Carothers et al.,
2006) suggests that it should appear by chance no more than
about once per 10 mammalian genomes, and it should be
readily isolated from random libraries of diversities >5e10,
as confirmed by several independent experiments (Burgstaller
and Famulok, 1994; Burke and Gold, 1997; Gebhardt et al.,
2000; Sassanfar and Szostak, 1993). We threaded the publicly
available reference genomes through the structure descriptors
and identified sequences capable of assuming the same fold.
Our search revealed a number of potential aptamers but very
few that perfectly matched the consensus structure identified
in vitro. Most candidate aptamers had weaker paired regions
or mutations in the binding loop, suggesting that they have lower
affinity for adenosine than the optimal in vitro-selected aptamers
(KD 1 mM).
In Vitro Activity of Aptamer Candidates
To test their in vitro activity, we transcribed the putative ap-
tamers from synthetic templates corresponding to the genomic
sequences, purified, and incubated with ATP-agarose beads at
conditions similar to the ones used for in vitro selections (Sas-
sanfar and Szostak, 1993). After extensive washing, the ap-
tamers were eluted with 5 mM AMP or ATP-Mg and the fraction
of specifically bound RNA was determined using scintillationlsevier Ltd All rights reserved
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Figure 2. Human RAB3C Adenosine Aptamer Discovered Using Structure-Based Bioinformatics
(A) Mapping of the aptamer sequence on to the primate RAB3C gene.
(B) Sequence alignment of the primate RAB3C aptamers, with the adenosine-binding loop underlined in red. The marmoset and chimp sequences have activity
similar to the human sequence (data not shown).
(C) Predicted secondary structure of the RAB3C aptamer, with the ligand-binding loop shown in red. Red and blue brackets indicate positions used to detect
ligand binding and in-line probing reference bands, respectively, shown in (E). 50 guanosine was introduced to facilitate in vitro transcription and is not present in
the genomic sequences.
(D) Binding of ATP column and elution with AMP (FT, flowthrough; C, fraction of RNA bound to the column after three AMP elution steps).
(E) In-line probing (Soukup and Breaker, 1999) of the 30-labeled aptamer at physiological-like conditions in the presence of AMP. The band intensities that change
with AMP concentration correspond to the predicted binding loop positions, confirming the predicted secondary structure. The sequence of the RNA was
determined using iodoethanol cleavage of aptamers with phosphorothioate-modified backbone at positions indicated above each lane. The aptamer shows
a single-nucleotide heterogeneity at its 30 end, resulting in doublets for all positions.
(F) Binding of the aptamer to ATP (closed triangles), AMP (open triangles), dATP (gray triangles), and GTP (closed circles) based on in-line probing experiments
and fit using a single-binding-site model (see Figure S1 for probing in the presence of ATP, dATP, and GTP). The dissociation constants for ATP and AMP
are 400 mM and 200 mM, respectively. Gray area corresponds to the concentration range of ATP in human tissues (Buchli et al., 1994; Kemp et al., 2007).
Chemistry & Biology
Human ATP Aptamerscounting. Several RNAs showed significant ATP binding and
competitive elution, including sequences mapping to genomes
of a bacterium and several vertebrates: Bacillus cytotoxicus,Chemistry & Biology 19, 1247–1Western clawed frog, mouse, marmoset, chimp, and human
(Figure 1C; the primate aptamers are almost identical, and their
alignment is shown in Figure 2B).254, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1249
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Figure 3. In Vitro-Selected Human FGD3 Adenosine Aptamer
(A) Mapping of the aptamer to the FGD3 intron.
(B) Aptamer sequence conservation among primates. Red bars indicate positions that form the adenosine-binding loop.
(C) Secondary structure of the aptamer based on in-line probing and thermodynamic structure predictions.
(D) Cotranscriptional binding of ATP-agarose beads and competitive elution with ATP-Mg under physiological-like conditions.
See Figure S2 for the secondary structure of the clone sequence, full alignment of primate sequences, and in-line data with ATP.
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Human ATP AptamersThe bacterial aptamer resides in a gene coding for an ABC
transporter, an ATP-binding permease protein. The aptamer
bound to an ATP column and eluted specifically in the presence
of free ATP or AMP (data not shown). The sequence was unique
to B. cytotoxicus (NVH391-98); other Bacillus species carry
mutations in both the adenosine recognition loop and the
flanking helices. While these mutations do not individually abro-
gate ligand binding (Dieckmann et al., 1997), their combination
resulted in complete loss of affinity for ATP-agarose, suggest-
ing that the aptamer is not a conserved regulatory element
among Bacillus species, but rather represents a possible gain-
of-function variant of a diverged Bacillus cereus species (Lapi-
dus et al., 2008).
The aptamers found in the frog (Xenopus tropicalis) andmouse
(Mus musculus) genomes also showed robust binding to ATP-
agarose column and elution in presence of free ATP (data not
shown). The frog aptamer maps to an intergenic region, and
the mouse aptamer maps antisense to a MIRc SINE element
in an intron of the Pelp1 gene, which codes for an estrogen
receptor coregulator. The distance from the end of the aptamer
to the next exon of the Pelp1 gene is only 88 nt, suggesting that
the aptamer may influence the splicing of the exon, but the
sequence is not conserved among rodents; therefore, it is un-
likely it has a broad biological role.
Characterization of the Human RAB3C Aptamer
The primate aptamer maps to the last intron of the RAB3C gene
(Figures 2A and 2B), which codes for a GTPase involved in regu-
lation of exocytosis (Schonn et al., 2010). The human sequence
bound an ATP column and eluted with AMP (Figure 2D) but not
with GMP. Mutation of the ‘‘opposing’’ guanosine of the recogni-
tion loop to adenosine abolished ATP binding, as was shown
previously for the in vitro-selected aptamers (Dieckmann et al.,1250 Chemistry & Biology 19, 1247–1254, October 26, 2012 ª2012 E1996). Partial hydrolysis of the RNA under physiological-like
conditions (37C, 140 mM KCl, 10 mM NaCl, 10 mM Tris-HCl
or 10 mM potassium phosphate, pH 7.9, 1 mM spermidine,
1 mM MgCl2), also known as in-line probing, showed signifi-
cant adenosine-dependent changes in the canonical adenosine
recognition loop (Soukup and Breaker, 1999) (Figure 2E). The
apparent dissociation constants (KDs) calculated from the char-
acteristic increase of degradation in the middle of the binding
loopwere200 mMand400 mM for AMP and ATP, respectively
(Figure 2F). No change in the degradation pattern was observed
in the presence of 20-dATP or GTP, confirming that the aptamer
is specific for adenosine (Figure S1 available online).
In Vitro Selection of Human Adenosine Aptamers
The discovery of a robust human adenosine aptamer led us to
consider two questions: (1) How many human aptamers exist?
and (2) Do human adenosine aptamers form multiple structural
families? To measure the distribution of all ATP aptamers in
the human genome, independent of structure or cellular expres-
sion, we performed an in vitro selection experiment from an
150 nt human genomic library (Salehi-Ashtiani et al., 2006).
We carried out the selection essentially as described elsewhere
(Sassanfar and Szostak, 1993), binding the pool of transcripts
to ATP-agarose beads and eluting the bound fraction with
ATP-Mg at physiological-like salt conditions described earlier.
This unbiased approach yielded another two aptamers: one
that maps antisense to a junction between an ERV1 LTR repeat
and its 30 insertion site, and another that resides in an intron of
the FGD3 gene (Figure 3), which codes for a guanyl nt exchange
factor regulating cell morphology and motility (Hayakawa et al.,
2008). It is surprising that both of these sequences were pre-
dicted to fold into the canonical structure found in the RAB3C
and in vitro-selected adenosine aptamers. ATP column bindinglsevier Ltd All rights reserved
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Human ATP Aptamersand ‘‘in-line’’ probing experiments of individual selection clones
showed robust binding to ATP by the predicted recognition loop
(KD 130 mM) (Figure S2). The aptamer found straddling the
ERV1 insertion site was not identified at other ERV1 insertion
sites, suggesting that the ability to bind adenosine is not gener-
ally associated with antisense transcripts of the ERV1 and that
this instance potentially represents a unique gain of function
facilitated by a mobile genetic element.
Cotranscriptional Binding of ATP by the Human FGD3
Aptamer
Because the FGD3 aptamer clones included the primer binding
sites introduced during the construction of the genomic library,
we also tested genomic sequences lacking these artificial
sequences. Even though the predicted secondary structure
suggested that the adenosine aptamer fold forms in absence
of the primer sequences, none of the genomic constructs bound
ATP under equilibrium conditions when a purified RNA was
incubated with either ATP beads or free ATP. The predicted
secondary structure included potential alternative folds, sug-
gesting that the lowest energy of the adenosine-free RNA may
prevent formation of the adenosine-binding loop. We reasoned
that, while the RNA had the ability to form the binding loop, as
evidenced by the in vitro-selected clone, once purified using
denaturing gel electrophoresis, the aptamer likely folded into
a nonbinding conformation. However, given that some ribos-
witches control gene expression kinetically, sensing ligand
concentrations during transcription in order to promote ter-
mination shortly after the synthesis of the aptamer domains
(Wickiser et al., 2005), we hypothesized that the adenosine-
binding conformation of the FGD3 aptamer could form tran-
siently during transcription. To test this hypothesis, we incu-
bated the in vitro transcription reaction in the presence of
ATP beads and measured the fraction of the newly transcribed
RNA that bound the beads and dissociated in the presence of
free ATP. Under these conditions, a significant fraction of the
aptamers bound ATP-agarose specifically (in the presence of
500 mM free ATP used for transcription) (Figure 3D). This result
suggested that the FGD3 aptamer may sense cellular ATP using
a kinetic mechanism, although any biological role for this RNA
remains to be elucidated.
DISCUSSION
To date, most riboswitches have been identified in bacteria
(Breaker, 2011), typically regulating transcription termination or
translation initiation, and a single example has been described
in algae, fungi, and plants where the thiamine pyrophosphate
riboswitch regulates alternative splicing or mRNA processing
(Cheah et al., 2007; Croft et al., 2007; Kubodera et al., 2003;
Wachter et al., 2007). Given the broad distribution of bacterial
riboswitches, the paucity of eukaryotic examples is surprising
and perhaps reflects the need for novel computational and
experimental tools for their discovery. Structure-based searches
for known aptamer motifs and direct in vitro selection of ligand-
binding RNAs used in this study show that both approaches yield
new eukaryotic ligand-binding RNAs, although their regulatory
function has yet to be demonstrated. The association of two of
the vertebrate aptamers with retrotransposons also indicatesChemistry & Biology 19, 1247–1that the evolution of functional RNAs in eukaryotic genomes
may be strongly coupled to the activity of mobile genetic
elements, potentially extending their gene regulatory functions
to include eukaryotic riboswitches.
Our results show that a bacterium and several vertebrates
harbor adenosine aptamers of the same structural family as
have been discovered using in vitro selections, demonstrating
that the convergent molecular evolution of adenosine binding
encompasses genomic sequences. In vitro selection from a
human genomic library revealed the same structural family,
indicating that the convergent evolution of adenosine-binding
RNAs extends to all human genomic aptamers. Previous studies
identified several synthetic aptamers and biological ribos-
witches that bind the same ligand (e.g., adenine, flavin mononu-
cleotide, S-adenosyl homocysteine) (Burgstaller and Famulok,
1994; Gebhardt et al., 2000; Mandal and Breaker, 2004; Meli
et al., 2002; Mironov et al., 2002; Weinberg et al., 2010; Winkler
et al., 2002), but adenosine is the only ligand for which the same
aptamer motif has been identified in both random pools and
genomes. The convergent molecular evolution spanning syn-
thetic and genomic sequences thus mirrors that of another
simple functional RNA, the hammerhead self-cleaving ribozyme
(Hammann et al., 2012; Salehi-Ashtiani and Szostak, 2001).
The biological functions of the adenosine aptamers remain
unknown. Our data suggest that the primate RAB3C and FGD3
aptamers may sense the ATP concentration using a kinetic
mechanism. In the case of the FGD3 aptamer, we detected
ATP binding only during transcription and not in equilibrium
experiments, supporting the hypothesis that the genomic
sequence assumes ATP-binding conformation only transiently
and any biological function associated with the aptamer would
have to be coupled to the cotranscriptional binding. The
RAB3C aptamer KD for ATP is about an order of magnitude
below the concentration of ATP, which, at 2 to 9 mM, is the
most concentrated adenosine-containing small molecule in
human tissues (Buchli et al., 1994; Kemp et al., 2007). Thus,
under equilibrium conditions and normal ATP levels, the aptamer
binding sites would be nearly saturated; however, if the cellular
ATP concentration decreased about 10 times, a significant frac-
tion of the aptamers would remain unoccupied. If the aptamer
domain is connected to a regulatory process, it may be used
to sense a large change in ATP concentration. Alternatively, if
the aptamer is coupled to a cotranscriptional regulatory process,
it may sense changes in ATP concentrations through a kinetic
mechanism, whereby the occupancy of the aptamer domain
would be proportional to the rate at which the ligand binds (Garst
et al., 2011; Zhang et al., 2010). A change of ATP concentration
within the normal physiological range of 2–9 mM would lead to
almost a 5-fold range of binding rates, and the range would be
even greater if the ATP concentration deviates significantly
from the normal levels. Thus any process kinetically coupled to
the rate of binding by ATP could be sensed by this aptamer.
Further experiments will be necessary to establish what, if any,
biological processes these aptamers affect.
SIGNIFICANCE
Aptamers are structuredmacromolecules in vitro evolved to
bind a variety of molecular targets. In biological systems,254, October 26, 2012 ª2012 Elsevier Ltd All rights reserved 1251
Box 1. Descriptors for Aptamers with the Recognition Loop in
the 50 and 30
#1
h1 r2 s1 r3 h4 s2 h40 r30 s3 r20 h10
h1 0:0 NNNN:NNNN
r2 0:0 N:N TGCA
s1 0 GGAAGAAMCUG
r3 0:0 N:N TGCA
h4 0:0 NNNN:NNNN
s2 0 NNN[10]
s3 0 G
#2
h1 r2 s1 r3 h4 s2 h40 r30 s3 r20 h10
h1 0:0 NNNN:NNNN
r2 0:0 N:N TGCA
s1 0 G
r3 0:0 N:N TGCA
h4 0:0 NNNN:NNNN
s2 0 NNN[10]
s3 0 GGAAGAAMCUG
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Human ATP Aptamersaptamers form the ligand-binding domains of ribos-
witches—cofactor-dependent cis regulatory RNAs. The
ligand-binding motifs identified in vitro and in riboswitches
are diverse, even for the same ligand, suggesting that
synthetic and biological aptamers follow separate evolu-
tionary paths to achieve high-binding specificity and affinity.
A paradigm of convergent molecular evolution among
aptamers is represented by the adenosine-binding motif,
which was identified in several independent in vitro experi-
ments, but had not been previously found in genomic
sequences. We used structure-based bioinformatics to
measure the distribution of these aptamers in genomes
and discovered that they map to organisms spanning from
bacteria to humans. The human aptamer is conserved
among primates, maps to an intron of the RAB3C gene,
and binds ATP with dissociation constant about 10 times
lower than physiological ATP concentration. Furthermore,
to experimentally measure the distribution of all human
adenosine-binding aptamers, independent of structure, we
performed an in vitro selection from a genomic library
and isolated two more aptamers. Both sequences fold into
the same structure as was identified in random sequences
and the RAB3C gene, demonstrating that its structural
convergence extends to all human adenosine aptamers.
One of the aptamers maps to an intron of the FGD3 gene
and exhibits full sequence conservation among primates,
but the genomic construct binds ATP exclusively cotran-
scriptionally and not in equilibrium experiments. The human
adenosine aptamers may be kinetically controlled ATP
sensors.
EXPERIMENTAL PROCEDURES
Structure-Based Searches
We used the RNABOB program (courtesy of S. Eddy, Howard Hughes
Medical Institute; ftp://selab.janelia.org/pub/software/rnabob/) to perform
motif searches (Riccitelli and Lupta´k, 2010). The secondary structure of the
adenosine aptamer was based on in vitro-selected RNAs that bind adeno-
sine-containing molecules: ATP (Sassanfar and Szostak, 1993), nicotinamide
adenine dinucleotide (Burgstaller and Famulok, 1994), S-adenosyl methionine
(Burke and Gold, 1997), and S-adenosylhomocysteine (Gebhardt et al., 2000).
In addition, we incorporated constraints based on the solution structures of the
AMP-bound aptamers (Dieckmann et al., 1996, 1997; Jiang et al., 1996). The
secondary structure was divided into the recognition loops (s1 and s3) flanked
by single strict base pairs (r2 and r3 elements). The rest of the helices were
allowed to contain G,U wobble pairs (h1 and h4 elements). Box 1 shows the
descriptors for aptamers with the recognition loop in the 50 (#1) and 30 (#2)
strands corresponding to the circularly permuted motif:
RNA Transcription
RNA was transcribed at 37C for 1 to 3 hours in a volume of 20 ml containing
40 mM Tris chloride, 10% dimethyl sulfoxide (DMSO), 10 mM dithiothreitol
(DTT), 2 mM spermidine, 2.5 mM each CTP, GTP, and UTP, 250 mM ATP,
2.25 mCi [a-32P]-ATP (Perkin Elmer, Waltham, MA, USA), 25 mM MgCl2, one
unit of T7 RNA polymerase, and 0.2 mM of DNA template. DMSO was used
to increase transcript yields, as documented in previous studies (Chen and
Zhang, 2005). The transcripts were purified using denaturing PAGE.
30-Terminus Labeling
RNA ligation reactions were performed essentially as previously described
(England et al., 1980). Briefly, RNA transcribed in the absence of [a-32P]-ATP
was PAGE purified and ligated at 37C for 3 hours in a volume of 10 ml, contain-
ing RNA ligase buffer (New England Biolabs [NEB] Ipswich, MA, USA), 2 mCi1252 Chemistry & Biology 19, 1247–1254, October 26, 2012 ª2012 E[50-32P] cytidine 30, 50-bisphosphate (Perkin Elmer) and one unit of T4 RNA
ligase (NEB) and PAGE purified again.
In-Line Probing
In-line probing reactions were performed as previously described (Regulski
and Breaker, 2008; Soukup and Breaker, 1999). The 30-end labeled RNA
was incubated with varying amounts of ligand for 1 or 2 days at 37C in a buffer
containing 140mMKCl, 10 mMNaCl, 10 mMpotassium phosphate, pH 7.9, or
Tris chloride, pH 7.9, 1 mM MgCl2, and 1 mM spermidine. Triphosphorylated
ligands (ATP, dATP, GTP) were prepared as 1:1 complexes with Mg2+. AMP
was used directly, without additional divalent metal ions. The partially hydro-
lyzed RNAs were resolved using denaturing PAGE, exposed to phosphor-
image screens (Molecular Dynamics/GE Healthcare, Pittsburgh, PA, USA),
and scanned by GE Typhoon phosphorimager. The band intensities were
analyzed by creating line profiles of each lane using ImageJ, exporting the
graphs into IgorPro, and fitting all peaks by Gaussian curves. The areas of
the fitted curves were used to measure intensity changes of the binding loop
and divided by intensities of a control band. The resulting ratios were plotted
in Excel as a function of ligand concentration and modeled with a dissociation
constant equation for a single ligand:
Fraction Bound=
 ½ligand
ð½ligand+KDÞ  Baseline

Range
:
The model was fit to the data using a linear least-squares analysis and the
Solver module of Microsoft Excel.
Sequence of the adenosine-binding loop were confirmed by running iodoe-
thanol-cleaved RNAs with a-phosphorothioate nt incorporated at indicated
positions (Gish and Eckstein, 1988; Ryder and Strobel, 1999). The dominant
product of phosphorothioate sequencing, a 20-30 cyclic phosphate, is the
same as in in-line probing (Soukup and Breaker, 1999), allowing a direct
readout of the positions affected by the bound ligand.
In Vitro Selection
The DNA pool used for the in vitro selection was derived from the human
genome and described previously (Salehi-Ashtiani et al., 2006). Purified RNA
transcripts were precipitated, dried, and resuspended in 200 ml binding bufferlsevier Ltd All rights reserved
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Human ATP Aptamerscontaining 140 mM KCl, 10 mM NaCl, 10 mM Tris chloride, pH 7.5, and 5 mM
MgCl2 and heated to 70
C before loading on to C8-linked ATP-agarose beads
(Sigma-Aldrich, St. Louis, MO, USA) equilibrated in the binding buffer. Flow-
through was collected after the columns were capped and shaken for
20 min at room temperature. The beads were washed with 200 ml of binding
buffer, and potential aptamers eluted with the same buffer supplemented by
5 mM ATP,Mg with 30 min of shaking at room temperature. Each fraction
was analyzed for radioactivity using a liquid scintillation counter. Elutions
were pooled, desalted using YM-10 spin filters (Millipore, Billerica, MA,
USA), precipitated, dried, and resuspended in H2O.
In Vitro Selection Primers
Forward: 50 GATCTGTAATACGACTCACTATAGGGCAGACGTGCCTCAC
TAC 30
Reverse: 50 CTGAGCTTGACGCATTG 30
Reverse Transcription
RNA was reverse transcribed in 20 ml using the Promega reverse transcription
buffer, 2 mM reverse primer, and RNA recovered from the previous selection
round. The RNA and primer were annealed by heating at 65C and cooling
to room temperature before 1 unit of Thermoscript (Invitrogen, Grand Island,
NY, USA) and Improm II (Promega, Madison, WI, USA) reverse transcriptases
each were added. The reaction was initiated for 5 min at 25C, and then the
temperature was ramped to 42C, 50C, 55C, and 65C for 15 min each
before the enzymes were inactivated at 85C for 5 min.
Amplification
DNA was amplified by using DreamTaq Master Mix (Fermentas, Glen Burnie,
MD, USA), 2 mM forward primer, 2 mM reverse primer, and DNA from reverse
transcription. DNA was initially denatured at 95C for 1.5 min (30 s for subse-
quent denaturing steps), annealed at 55C for 30 s, and extended at 72C for
each cycle. Optimum number of PCR cycles was determined for each selec-
tion round by comparing 8-, 12-, 16-, and 20-cycle aliquots on agarose gel.
Cloning
After five rounds of selection, the pool was cloned using the Topo TA cloning
kit (Invitrogen) and individual colonies were directly PCR amplified and
sequenced. Only two unique sequences, the FGD3 and ERV1, were found:
FDG3 (chr9:95,787,061-95,787,193)
GGTCCTGG GGAGTCTAAC CCCCGGGTTG GTGCCCTGAC AGGAGgATGT
TCTtGCTGGA AGAACCTGCA AGGCCATTGT TTAAgATGTT TTAACTTGTG
GGAAGACACA GCTTGGAGAT GGCCTTGGAG.
ERV1 (chr3:162359023-162359154)
AGAAGC AAGAAGGAAG AAAcTGCCAc CGTTGTCATC TTGTGTCTGa AAT
TGGTGGn TTCTTGGTCT CACTGgCTTC AAGAATGAAG CCGTGGACCC TC
GCGGTGAG TGTTACAGTT CTTAAAGGCG GTGTCT.
Lowercase letters are mutations acquired during the in vitro selection or
library construction, as compared with the reference genome. The putative
adenosine-binding loop is highlighted in bold. The ERV1 aptamer contained
an A-to-C mutation in the recognition loop (underlined) in all sequenced
clones. The genomic sequence is likely to bind adenosine, because this variant
has been observed among in vitro-selected clones (Sassanfar and Szostak,
1993). As with the other two aptamers, in-line probing showed an ATP-depen-
dent change in the hydrolysis pattern for the predicted loop characteristic of
this class of aptamers (Soukup and Breaker, 1999), confirming that the cloned
sequence forms the same binding loop.
Co-transcriptional Binding Assay
RNAwas transcribed in aSpin-Xcolumn (Corning,Corning,NY,USA) for 30min
at 37C in 50 ml solution containing 40 mM Tris chloride, 10% DMSO, 10 mM
DTT, 5mMeachGTP,UTP, andCTP, 500 mMATP, 3.75mCi [a-32P]-ATP (Perkin
Elmer), 25 mMMgCl2, 1 unit of T7 RNA polymerase, 50 pmol of DNA template,
and C8-linked ATP-agarose beads, washed, and equilibrated in transcription
buffer. The columns were centrifuged at 4,000 g for 1 min, and flowthrough
was collected. The columns were washed in 50 ml of the binding buffer and
centrifuged. Elutions were collected in the ATP,Mg elution buffer following
30 min of shaking. Each fraction was resolved on a denaturing PAGE gel to
separate the full-length transcripts from unincorporated [a-32P]-ATP andChemistry & Biology 19, 1247–1shorter transcripts. The gels were exposed to phosphorimage plate and
scanned, and the amount of full-length RNAsmeasured with ImageJ software.
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